Visit us at WC2024 on Electroporation and Pulsed Electric Fields in Biology, Medicine, and Food & Environmental Technologies at the Faculty of Engineering, Sapienza University of Rome!
It’s an honor to be able to participate in this important conference organised by the International Society for Electroporation-Based Technologies and Treatments (ISEBTT) both as sponsors and speakers! We are ready to contribute with speeches from our CEO Luigi Aurisicchio, and our researcher Erika Salvatori. Luigi will deliver two speeches on Tuesday 17th:– “Development of […]
September 11th-12th, the 10th IBP BIOSAFETY CONFERENCE that took place in Siena, in Fondazione Toscana Life Science Auditorium
A workshop designed to foster the knowledge and sharing experience about specialized #biosafety issues, with the aim of growing people’s competence. There were several heterogeneous talks referring to the field of biosafety. We were present at the IBP Conference as supporters and speakers. We talked about the implementation of the #BSL3 facility at our HQ, […]
Madeira was amazing! And even more the “Antibody Series” Congress”, where our CSO Giuseppe Roscilli participated.
It was a remarkable experience, from September 3rd to 6th, with a variety of conferences and events set against the stunning backdrop of the Portuguese island of Madeira. This event provided the perfect opportunity to enrich scientific knowledge discussing topics like the engineering of antibodies, new targets and technologies, computation and prediction, all areas where […]
Spoke 6 – International Young Researcher Workshop
Takis at the #RomeTechnopole Spoke 6 – International Young Researcher #Workshop! This workshop was held last week at Sapienza Università di Roma and our team, led by our CTO Giuseppe Roscilli, was there to share some of our cutting-edge #research projects. Valerio Chiarini, Ph.D. presented on “MATCH: An in-silico drive-through for mAbs discovery”. This innovative […]
Takis al 12° AIS Congress a Montpellier!
We are excited to share our recent participation in the AIS Congress at Le Corum – Palais de Congrès in #Montpellier, where our own Giuseppe Roscilli and Alessia Muzi presented the results of our latest #research projects in #antibody production and purification. The first one that we shared was “Efficient Generation, B Cell Isolation, and […]
Takis participated at the Flagship Project 7 Mid-term plenary workshop!
But first… what’s Flagship Project 7? Flagship Project 7 (FP7) is one of eight projects under the #RomeTechnopole initiative: a set of initiatives that bring vertical innovation within strategic specialization areas such as Energy Transition, Digital Transition, and #Health & #BioPharma. FP7 is led by Takis and Catalent, working closely with CNR, Istituto Superiore di […]
European Association for Cancer Research (EACR) Annual Congress 2024
During the European Association for Cancer Research (EACR) Annual Congress 2024 for Innovative Cancer Science in #Rotterdam, we had the opportunity to present our internal #research: “Targeting HER3 in Cancer Therapy: Pioneering Approaches through DNA Vaccination and Monoclonal Antibody Development.” This study introduced a dual approach targeting #HER3 with a therapeutic #vaccine and a novel […]
Takis at EACR2024: Innovation in Cancer Therapy
We are excited to share our recent participation in the EACR2024 #event in Rotterdam, where laura luberto and Alessia Muzi presented the results of one of our latest #research projects in cancer therapy. Our research focuses on the HER3 receptor, a crucial member of the ErbB receptor family, known for its role in cellular regulation […]
In an incredibly sunny London, our CTO Giuseppe Roscilli had the pleasure to present our innovative approaches for generating and producing monoclonal antibodies at the Antibody and Engineering Therapeutics Congress.
Utilizing #technologies like DNA-EGT, we efficiently produce high-quality antibodies, surpassing the limitations of conventional methods. Our high-throughput techniques for screening antibody phenotypes and antigen specificity from primary B cells provide a cost-effective and efficient platform for identifying antigen-specific antibodies from human and mouse B cells. These advancements are combined with high-troughput antibody production and purification, […]
Italy and Latin America: Exploring New Frontiers in Biotechnology and Life Sciences
Our CEO, Luigi Aurisicchio, recently joined the event “Italy and Latin America: Exploring New Frontiers in Biotechnology and Life Sciences,” organized by IILA, the Embassy of Chile in Italy, and the Biotech Academy of Rome. This important gathering highlighted prospects, opportunities, and challenges for biotechnological development and training. Luigi showcased Takis’s innovative services and the […]